India Claims to Be Developing Anti-Omicron mRNA Vaccine

India’s Gennova Biopharmaceuticals is allegedly working to develop an “omicron-specific” Chinese coronavirus vaccine candidate based on mRNA technology that could be available to the public as soon as February, Reuters reported on Monday citing an unnamed company spokesman who confirmed the development via text message.

A healthcare worker administers a shot of China's Sinopharm COVID-19 vaccine at the Guru N